Exagen Shares Outstanding 2019-2024 | XGN
Exagen shares outstanding from 2019 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Exagen Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 18 |
| 2023 | 18 |
| 2022 | 17 |
| 2021 | 16 |
| 2020 | 13 |
| 2019 | 4 |
| 2018 | 0 |
| Exagen Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-12-31 | 18 |
| 2024-09-30 | 18 |
| 2024-06-30 | 18 |
| 2024-03-31 | 18 |
| 2023-12-31 | 18 |
| 2023-09-30 | 18 |
| 2023-06-30 | 18 |
| 2023-03-31 | 18 |
| 2022-12-31 | 17 |
| 2022-09-30 | 17 |
| 2022-06-30 | 17 |
| 2022-03-31 | 17 |
| 2021-12-31 | 16 |
| 2021-09-30 | 17 |
| 2021-06-30 | 17 |
| 2021-03-31 | 13 |
| 2020-12-31 | 13 |
| 2020-09-30 | 13 |
| 2020-06-30 | 13 |
| 2020-03-31 | 13 |
| 2019-12-31 | 4 |
| 2019-09-30 | 2 |
| 2019-06-30 | 0 |
| 2019-03-31 | 0 |
| 2018-12-31 | |
| 2018-09-30 | 0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $0.111B | $0.056B |
| Exagen Inc. is engaged in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases. It developed and commercialises testing products under AVISE brand. Exagen Inc. is based in Vista, California. | |||